Comparative Effectiveness of Intervention in Multi-level Hospitals for Acute Traumatic Brain Injury(Metric-TBI)
Key facts
- Who runs it
- Beijing Tiantan Hospital
- Where
- China64 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 2,000 people, planned
- Started
- 1 Aug 2024
- Expected to end
- 31 Dec 2026
- Type of study
- Observational
- Treatments tested
- Neurological function
- Mental State, cognitive function, and life quality assessment
- Peripheral blood test
- Hematoma test
- Record updated
- 4 September 2024
Who can take part
- Age
- 1 year to 89 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patient (1 years to 89 years) presenting with clinical symptoms of traumatic brain injury
- Traumatic brain injury verified on cranial computed tomography or magnetic resonance imaging
- Written informed consent from patients or their next of kin according to the patient's cognitive status
Who cannot take part
- patients with concomitant cancer or other serious illnesses
- patients ≥90 years of age
- patients who did not accept follow-up visits or were unable to complete follow-up assessments
- patients with incomplete information
- patients who did not obtain written informed consent
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 1 and 89 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
A prospective, multicenter, observational cohort study is designed to compare the effectiveness of intervention in multi-grade hospitals for acute traumatic brain injury and to optimize clinical outcomes.
The group in the trial
- TBI Group
TBI patients recruited from neurosurgical departments at 50 medical centers in China have apparent clinical symptoms that are confirmed by computed tomography or magnetic resonance imaging. The exclusion criteria are those who fulfill one of the following conditions: 1. patients ≥90 years of age; 2. patients who did not accept follow-up visits or were unable to complete follow-up assessments; 3. patients with incomplete information; 4. patients who did not obtain written informed consent; 5. patients with concomitant cancer or other serious illnesses.
Treatment: Neurological function, Mental State, cognitive function, and life quality assessment, Peripheral blood test, and Hematoma test
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparative Effectiveness of Intervention in Multi-level Hospitals for Acute Traumatic Brain Injury: a Prospective, Multicenter, Observational Cohort Study
- Criteria questions
- Built from NCT06429774, who can take part
- Record updated
- 4 September 2024